Literature DB >> 28794182

Membrane Filtration Is Suitable for Reliable Elimination of Mycobacterium tuberculosis from Saliva for Therapeutic Drug Monitoring.

Simone H J van den Elsen1, Tridia van der Laan2, Onno W Akkerman3,4, Adri G M van der Zanden5,6, Jan-Willem C Alffenaar7, Dick van Soolingen2,8.   

Abstract

Entities:  

Keywords:  Mycobacterium tuberculosis; biosafety; membrane filtration; saliva; therapeutic drug monitoring

Mesh：

Year:  2017        PMID： 28794182      PMCID： PMC5654913          DOI： 10.1128/JCM.01248-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics.

Authors:  Samiksha Ghimire; Mathieu S Bolhuis; Marieke G G Sturkenboom; Onno W Akkerman; Wiel C M de Lange; Tjip S van der Werf; Jan-Willem C Alffenaar
Journal:  Eur Respir J       Date:  2016-03-17       Impact factor: 16.671

2.  Quantitative studies of mycobacterial populations in sputum and saliva.

Authors:  H Yeager; J Lacy; L R Smith; C A LeMaistre
Journal:  Am Rev Respir Dis       Date:  1967-06

3.  Laboratory-acquired tuberculosis.

Authors:  P G Peerbooms; G J van Doornum; H van Deutekom; R A Coutinho; D van Soolingen
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

Review 4.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

5.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079
  5 in total
  4 in total

1.  Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis.

Authors:  Samiksha Ghimire; Bhagwan Maharjan; Erwin M Jongedijk; Jos G W Kosterink; Gokarna R Ghimire; Daan J Touw; Tjip S van der Werf; Bhabana Shrestha; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 2.  Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.

Authors:  Johanna Kuhlin; Marieke G G Sturkenboom; Samiksha Ghimire; Ioana Margineanu; Simone H J van den Elsen; Noviana Simbar; Onno W Akkerman; Erwin M Jongedijk; Remco A Koster; Judith Bruchfeld; Daan J Touw; Jan-Willem C Alffenaar
Journal:  Clin Mass Spectrom       Date:  2018-10-19

3.  Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania.

Authors:  Sagal Mohamed; Happiness C Mvungi; Margaretha Sariko; Prakruti Rao; Peter Mbelele; Erwin M Jongedijk; Claudia A J van Winkel; Daan J Touw; Suzanne Stroup; Jan-Willem C Alffenaar; Stellah Mpagama; Scott K Heysell
Journal:  J Antimicrob Chemother       Date:  2021-05-12       Impact factor: 5.790

4.  A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.

Authors:  Jan-Willem C Alffenaar; Erwin M Jongedijk; Claudia A J van Winkel; Margaretha Sariko; Scott K Heysell; Stellah Mpagama; Daan J Touw
Journal:  J Antimicrob Chemother       Date:  2021-01-19       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.